← Leaderboards
Nazneen N Dewji
University Of California San Diego
$17,656,949
Attributed
$17,656,949
Total exposure
9
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.8M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,656,949 · 9
By mechanism
R44$11,605,707 · 3
R01$5,564,463 · 4
R43$486,779 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of California San Diego
Same institution · by research overlap
- Gerard David Schellenberg$94,178,901
- Dale E. Bredesen$12,603,293
- Douglas R Galasko$47,442,835
- Patricia A Thistlethwaite$7,394,079
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposS DiseaseBrainPresenilinCell PhysiologyIn VitroSecretaseAffectDrug CandidateTransgenic MicePresenilin-1New TechnologyPharmacotherapyPeptide DrugPharmaceutical PreparationsAmyloid Beta-ProteinNeurotoxicSmall Business Innovation Research GrantIn VivoDrug KineticsAbeta SynthesisEnzymesGamma SecretaseAmino Acids
Grant awards (31)
EARLY CLINICAL DEVELOPMENT OF MODIFIED P8 FOR THE TREATMENT OF ALZHEIMER'S DISEASE$1,633,354
R44 · FY2025 · AG · contact PI
EARLY CLINICAL DEVELOPMENT OF MODIFIED P8 FOR THE TREATMENT OF ALZHEIMER'S DISEASE$1,041,646
R44 · FY2024 · AG · contact PI
IND-Enabling Pre-clinical Development of Modified P8 for the Treatment of Alzheimer's Disease$1,610,358
R44 · FY2021 · AG · contact PI
IND-Enabling Pre-clinical Development of Modified P8 for the Treatment of Alzheimer's Disease$101,144
R44 · FY2021 · AG · contact PI
IND-Enabling Pre-clinical Development of Modified P8 for the Treatment of Alzheimer's Disease$1,750,000
R44 · FY2020 · AG · contact PI
Small molecule therapeutics for Alzheimer's Disease$999,998
R44 · FY2019 · AG · contact PI
Small molecule therapeutics for Alzheimer's Disease$374,500
R44 · FY2019 · AG · contact PI
Small molecule therapeutics for Alzheimer's Disease$999,998
R44 · FY2018 · AG · contact PI
Progressing the Pre-clinical development of P8 for Alzheimer's Disease$747,850
R44 · FY2018 · AG · contact PI
Progressing the Pre-clinical development of P8 for Alzheimer's Disease$750,000
R44 · FY2017 · AG · contact PI
Intranasal Delivery of Peptide Drugs to the Brain$99,960
R44 · FY2017 · AG · contact PI
Intranasal Delivery of Peptide Drugs to the Brain$746,899
R44 · FY2016 · AG · contact PI
Small molecule therapeutics for Alzheimer's Disease$225,000
R43 · FY2016 · AG · contact PI
Intranasal Delivery of Peptide Drugs to the Brain$750,000
R44 · FY2015 · AG · contact PI
Intranasal Delivery of Peptide Drugs to the Brain$261,779
R43 · FY2012 · AG · contact PI
The Presenilins as G-Protein Coupled Receptors$331,209
R01 · FY2011 · NS · contact PI
The Presenilins as G-Protein Coupled Receptors$334,590
R01 · FY2010 · NS · contact PI
The Presenilins as G-Protein Coupled Receptors$337,969
R01 · FY2009 · NS · contact PI
The Presenilins as G-Protein Coupled Receptors$337,969
R01 · FY2008 · NS · contact PI
The Presenilins as G-Protein Coupled Receptors$337,969
R01 · FY2007 · NS · contact PI
Mechanisms of beta-Amyloid Precursor Protein Processing in the Brain$333,286
R01 · FY2007 · NS · contact PI
Mechanisms of beta-APP Processing in the Brain$343,240
R01 · FY2006 · NS · contact PI
Mechanisms of beta-APP Processing in the Brain$351,500
R01 · FY2005 · NS
Mechanisms of beta-APP Processing in the Brain$346,349
R01 · FY2004 · NS
CELLULAR FUNCTIONS OF ALZHEIMER'S DISEASE PROTEINS$342,000
R01 · FY2004 · AG
CELLULAR FUNCTIONS OF ALZHEIMER'S DISEASE PROTEINS$342,000
R01 · FY2003 · AG
CELLULAR FUNCTIONS OF ALZHEIMER'S DISEASE PROTEINS$342,000
R01 · FY2002 · AG
BETA AMYLOID DERIVATION IN BRAIN IN ALZHEIMERS DISEASE$409,315
R01 · FY2001 · NS
CELLULAR FUNCTIONS OF ALZHEIMER'S DISEASE PROTEINS$341,719
R01 · FY2001 · AG
BETA AMYLOID DERIVATION IN BRAIN IN ALZHEIMERS DISEASE$397,391
R01 · FY2000 · NS
CELLULAR FUNCTIONS OF ALZHEIMER'S DISEASE PROTEINS$335,957
R01 · FY2000 · AG